| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Allergy and Asthma Care is a Germantown, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
US HealthConnect is a Fort Washington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Burke Rehabilitation Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. The Burke Rehabilitation Hospital is based in White Plains, NY. You can find more information on The Burke Rehabilitation Hospital at www.burke.org
Healthy Environments is a Mooresville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.